You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Business

Mass. Mover

Aveo Oncology seeks FDA approval for kidney cancer drug

Aveo currently has more than 300 employees.

Globe/File

Aveo currently has more than 300 employees.

Continue reading below

Aveo Oncology has submitted a new drug application to the Food and Drug Administration for a potential treatment for advanced kidney cancer. The Cambridge company has a deal with Japanese drug maker Astellas Pharma Inc. to commercialize tivozanib in some other countries. The application asks the FDA for approval to market tivozanib in the United States for patients with advanced renal cell carcinoma. An estimated 250,000 people are diagnosed with kidney cancer annually.

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week